本文關(guān)鍵詞： APRI FIB-4 肝衰竭 預(yù)后　出處：《新疆醫(yī)科大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

【摘要】：目的:探究APRI評分及FIB-4指數(shù)在慢性肝衰竭預(yù)后評估中的應(yīng)用價(jià)值。方法:回顧性分析2005年3月至2014年9月隨訪期滿3個月的新疆醫(yī)科大學(xué)第一附屬醫(yī)院感染性疾病中心426例慢性肝衰竭患者資料,計(jì)算患者診斷為慢性肝衰竭時(shí)的MELD評分、APRI評分及FIB-4指數(shù)。應(yīng)用單因素及多因素分析,繪制受試者工作特征曲線(ROC曲線),評價(jià)各評分方法預(yù)測患者3個月預(yù)后的價(jià)值。結(jié)果:單因素分析顯示APRI評分在生存組和死亡組之間差異無統(tǒng)計(jì)學(xué)意義(P0.05),FIB-4指數(shù)在生存組和死亡組之間差異有統(tǒng)計(jì)學(xué)意義(P0.05),多因素分析示APRI評分及FIB-4指數(shù)在生存組和死亡組之間均有統(tǒng)計(jì)學(xué)意義(P0.05);MELD評分、APRI評分、FIB-4指數(shù)AUC分別為0.6353、0.4888、0.6162,MELD評分和FIB-4指數(shù)與APRI評分間差異有統(tǒng)計(jì)學(xué)意義(P0.05),其中MELD評分及FIB-4指數(shù)間差異無統(tǒng)計(jì)學(xué)意義(P0.05),當(dāng)MELD評分大于28分、FIB4指數(shù)大于11.27分時(shí)患者3個月病死率高,預(yù)后差;426例患者中,FIB-43.25者(n=59),病死率為33.9%,大于3.25者共367例,病死率為61.04%,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:APRI評分在評估慢性肝衰竭預(yù)后未顯示應(yīng)用價(jià)值,FIB-4指數(shù)在慢性肝衰竭預(yù)后評估中有應(yīng)用價(jià)值,其預(yù)測慢性肝衰竭價(jià)值不差于MELD評分,且FIB-4指數(shù)越高,慢性肝衰竭預(yù)后越差。
[Abstract]:Objective: to explore the value of APRI score and FIB-4 index in evaluating the prognosis of chronic liver failure. Methods: the infectious diseases in the first affiliated Hospital of Xinjiang Medical University were analyzed retrospectively from March 2005 to September 2014. Data of 426 patients with chronic liver failure, The MELD score and FIB-4 index of the patients with chronic liver failure were calculated. Univariate and multivariate analysis were used. Results: univariate analysis showed that there was no significant difference in APRI score between survival group and death group. There was significant difference between survival group and death group (P 0.05). Multivariate analysis showed that APRI score and FIB-4 index were statistically significant between survival group and death group. AUC of AUC was 0.63530.48880.86162meld, FIB-4 index and APRI. There was no significant difference between MELD score and FIB-4 index (P 0.05). When the MELD score was more than 28 points and the FIB4 index was greater than 11.27, the mortality rate was higher in 3 months. In 426 patients with poor prognosis, there were 43.25 cases with FIB-43.25 and 367 cases with fatality rate of 33.9and more than 3.25, respectively. The mortality rate was 61.04, and the difference was statistically significant (P 0.05). Conclusion the value of FIB-4 index in evaluating the prognosis of chronic liver failure is not significant. The value of FIB-4 index in predicting the prognosis of chronic liver failure is not worse than that of MELD score. The higher the FIB-4 index, the worse the prognosis of chronic liver failure.
【學(xué)位授予單位】：新疆醫(yī)科大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R575.3

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 ;慢性乙型肝炎病毒感染預(yù)防、關(guān)懷和治療指南[J];中國病毒病雜志;2015年05期

2 唐尚軍;王于梅;李慶;羅濤;余灝東;;實(shí)時(shí)超聲彈性成像技術(shù)及APRI對慢性肝病早期纖維化的診斷價(jià)值[J];重慶醫(yī)學(xué);2015年25期

3 秦浩;尹華發(fā);;瞬時(shí)彈性成像聯(lián)合APRI在慢性乙型肝炎肝纖維化診斷中的應(yīng)用價(jià)值[J];安徽醫(yī)學(xué);2015年05期

4 劉杰玉;馮義朝;;多種肝衰竭預(yù)后模型的對比分析[J];臨床肝膽病雜志;2014年10期

5 周家玲;魏巍;尤紅;;肝纖維化無創(chuàng)診斷技術(shù)的臨床研究及進(jìn)展[J];臨床肝膽病雜志;2014年07期

6 劉京;劉映霞;董常峰;姚思敏;李莎茜;袁靜;陳川鐵;趙美芬;林益敏;彭忠田;;ARFI、Forns指數(shù)、FIB-4和APRI無創(chuàng)診斷慢性乙型病毒性肝炎肝纖維化的研究[J];中國肝臟病雜志(電子版);2014年01期

7 程捷瑤;馬紅;;慢性肝病肝纖維化無創(chuàng)診斷的研究進(jìn)展[J];臨床肝膽病雜志;2014年02期

8 嚴(yán)福華;羅先富;;CT、磁共振定量診斷肝纖維化的研究進(jìn)展[J];臨床肝膽病雜志;2013年10期

9 韓軼;劉立新;;肝纖維化血清學(xué)診斷指標(biāo)研究進(jìn)展[J];中華消化病與影像雜志(電子版);2013年04期

10 紀(jì)冬;陳國鳳;;肝纖維化無創(chuàng)診斷研究進(jìn)展及其臨床應(yīng)用[J];傳染病信息;2013年03期

，

本文編號：1539121